These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3897944)

  • 1. [Changes in serum prostaglandin metabolites in Schönlein-Henoch purpura].
    Túri S; Belch JJ; Beattie TJ
    Orv Hetil; 1985 Aug; 126(31):1901-4. PubMed ID: 3897944
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura.
    Turi S; Belch JJ; Beattie TJ; Forbes CD
    Arch Dis Child; 1986 Feb; 61(2):173-7. PubMed ID: 2420289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma thromboxane A2 and prostaglandin I2 levels and their ratio in children with Henoch-Schonlein purpura nephritis].
    Lu XY; Yang HY; Yang QZ; Liang J; Zhu YP; Dong SY; Sun WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):343-5. PubMed ID: 18554464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura.
    Túri S; Nagy J; Haszon I; Havass Z; Németh M; Bereczki C
    Pediatr Nephrol; 1989 Jan; 3(1):61-7. PubMed ID: 2518449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
    Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
    Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura.
    Abend NS; Licht DJ; Spencer CH
    Pediatr Neurol; 2007 May; 36(5):345-7. PubMed ID: 17509470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could it be Henoch-Schonlein purpura?
    Lim DC; Cheng LN; Wong FW
    Aust Fam Physician; 2009 May; 38(5):321-4. PubMed ID: 19458803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of coagulation parameters in the Schönlein-Henoch syndrome. Diagnostic value of factor XIII].
    Barberio G; Manganaro R; Ruggeri C; Cambria R; Gattarello A; Gemelli M
    Minerva Pediatr; 1981 Aug; 33(16):817-20. PubMed ID: 7311944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephropathy in the course of Schönlein-Henoch purpura].
    Rapacka E; Ostrowska-Nawarycz L; Baszczyński J; Makowska J; Kudzin J; Makowski M; Kudzin A; Górski P
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():31-2. PubMed ID: 11081341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum levels of IL-5 and LTB4 in children with Henoch-Schonlein purpura].
    Liao PY; Wu SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):198-200. PubMed ID: 16787590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schönlein-Henoch syndrome: review of a series of 142 cases].
    García E; Santos F; Suárez MD; Diéguez MA; Málaga S; Crespo M
    An Esp Pediatr; 1985 Jun; 22(8):557-63. PubMed ID: 4051340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with Henoch-Schonlein purpura.
    Shin JI; Lee JS; Kim HS
    Scand J Rheumatol; 2009; 38(1):73-4; author reply 74-5. PubMed ID: 19191188
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased formation of thromboxane A2 and prostacyclin in anaphylactoid purpura.
    Tönshoff B; Momper R; Schweer H; Schärer K; Seyberth HW
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():645-8. PubMed ID: 1825391
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiphospholipid antibodies in children with Henoch-Schonlein purpura: a prospective study from North India.
    Salhan M; Ahluwalia J; Singh S; Minz RW
    Scand J Rheumatol; 2007; 36(6):482-4. PubMed ID: 18092274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of peripheral blood dendritic cell functions in children with Henoch-Schonlein purpura and in vitro effect of Astragalus membranaceus].
    Chen YX; Zhang QY; Wang J
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):708-9. PubMed ID: 19099866
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin levels in Henoch-Schonlein purpura.
    Muslu A; Islek I; Gok F; Aliyazicioglu Y; Dagdemir A; Dundaroz R; Kucukoduk S; Sakarcan A
    Pediatr Nephrol; 2002 Nov; 17(11):920-5. PubMed ID: 12432435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in children after Henoch-Schonlein purpura nephritis.
    Butani L; Morgenstern BZ
    Clin Pediatr (Phila); 2007 Jul; 46(6):505-11. PubMed ID: 17579102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of factors VIII and IX in a child with Henoch-Schönlein syndrome.
    Gouyon JB; Seiller F; Deries X; Alison M; Lorenzini JL; Devilliers E
    Am J Pediatr Hematol Oncol; 1985; 7(4):376-7. PubMed ID: 3936372
    [No Abstract]   [Full Text] [Related]  

  • 19. Henoch-Schönlein purpura in a child with hyperimmunoglobulinemia D and periodic fever syndrome.
    Wickiser JE; Saulsbury FT
    Pediatr Dermatol; 2005; 22(2):138-41. PubMed ID: 15804303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of plasma D-dimer in the course of Henoch-Schönlein purpura.
    Zajadacz B; Juszkiewicz A
    Wiad Lek; 2005; 58(9-10):581-3. PubMed ID: 16529076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.